| Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment S Shah, D Danda, C Kavadichanda, S Das, MB Adarsh, VS Negi Rheumatology International 40 (10), 1539-1554, 2020 | 143 | 2020 |
| Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States R Raiker, C DeYoung, H Pakhchanian, S Ahmed, C Kavadichanda, ... Seminars in arthritis and rheumatism 51 (5), 1057-1066, 2021 | 81 | 2021 |
| Deficiency of adenosine deaminase 2 in adults and children: experience from India A Sharma, G Naidu, V Sharma, S Jha, A Dhooria, V Dhir, P Bhatia, ... Arthritis & Rheumatology 73 (2), 276-285, 2021 | 50 | 2021 |
| Lupus retinopathy: a marker of active systemic lupus erythematosus G Seth, KG Chengappa, DP Misra, R Babu, P Belani, KC Shanoj, ... Rheumatology international 38 (8), 1495-1501, 2018 | 49 | 2018 |
| Spondyloarthritis and the human leukocyte antigen (HLA)-B* 27 connection CG Kavadichanda, J Geng, SN Bulusu, VS Negi, M Raghavan Frontiers in immunology 12, 601518, 2021 | 46 | 2021 |
| Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic C Kavadichanda, S Shah, A Daber, D Bairwa, A Mathew, S Dunga, ... Rheumatology 60 (7), 3369-3379, 2021 | 43 | 2021 |
| Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: observations from an Indian inception cohort M Rathi, P Singh, HP Bi, A Shivanna, C Kavadichanda, SR Tripathy, ... Lupus 30 (1), 158-164, 2021 | 30 | 2021 |
| Short term outcomes of COVID-19 in lupus: propensity score matched analysis from a nationwide multi-centric research network R Raiker, H Pakhchanian, C DeYoung, L Gupta, S Kardeş, S Ahmed, ... Journal of Autoimmunity 125, 102730, 2021 | 27 | 2021 |
| Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis BNR Michael, V Kommoju, C Kavadichanda Ganapathy, VS Negi Rheumatology International 39 (8), 1377-1387, 2019 | 20 | 2019 |
| APLAR recommendations on the practice of telemedicine in rheumatology S Ahmed, R Grainger, A Santosa, A Adnan, KA Alnaqbi, YH Chen, ... International Journal of Rheumatic Diseases 25 (3), 247-258, 2022 | 19 | 2022 |
| Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network R Raiker, H Pakhchanian, C Kavadichanda, L Gupta, S Kardeş, S Ahmed Clinical rheumatology, 1-10, 2022 | 19 | 2022 |
| Clinical correlates of HLA‐B* 27 and its subtypes in enthesitis‐related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients CG Kavadichanda, G Seth, G Kumar, R Gulati, VS Negi International journal of rheumatic diseases 22 (7), 1289-1296, 2019 | 19 | 2019 |
| Systemic lupus erythematosus and overlap: A clinician perspective S Shah, KG Chengappa, VS Negi Clinical Dermatology Review 3 (1), 12-17, 2019 | 18 | 2019 |
| De Novo Crohn's disease triggered after COVID-19: is COVID-19 more than an infectious disease? K Senthamizhselvan, R Ramalingam, P Mohan, C Kavadichanda, ... ACG Case Reports Journal 8 (8), e00652, 2021 | 17 | 2021 |
| Management of Takayasu arteritis DP Misra, K Singh, U Rathore, CG Kavadichanda, M Ora, N Jain, ... Best Practice & Research Clinical Rheumatology, 101826, 2023 | 14 | 2023 |
| Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients A Fierabracci, A Arena, F Toto, N Gallo, A Puel, M Migaud, M Kumar, ... Journal of Endocrinological Investigation 44, 661-677, 2021 | 14 | 2021 |
| COVID-19 outcomes in patients with dermatomyositis: a registry-based cohort analysis H Pakhchanian, H Khan, R Raiker, S Ahmed, C Kavadichanda, M Abbasi, ... Seminars in arthritis and rheumatism 56, 152034, 2022 | 13 | 2022 |
| Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study SK Dunga, C Kavadichanda, L Gupta, R Naveen, V Agarwal, VS Negi Rheumatology International 42 (7), 1155-1165, 2022 | 12 | 2022 |
| Multiple drug intolerance syndrome: an underreported distinct clinical entity SK Behera, S Das, KG Chengappa, AS Xavier, S Selvarajan Current Clinical Pharmacology 14 (2), 84-90, 2019 | 12 | 2019 |
| Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients N Muralidharan, R Sundaram, S Kodidela, KG Chengappa, ... The Pharmacogenomics Journal 20 (2), 342-349, 2020 | 10 | 2020 |
Vir Singh NegiJIPMER, Pondicherry INDIAVerified email at jipmer.edu.in
